Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norditropin in Noonan Syndrome
NCT01529840Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 1990
- Primary completion
- Sep 2005
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in Noonan syndrome, sponsored by Novo Nordisk. Started Jun 1990; status: completed.
02
Drugs
somatropin
03
Conditions
Noonan syndrome
Beyond the preview
Go deeper on NCT01529840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529840.